Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma
Crossref DOI link: https://doi.org/10.1186/s13046-016-0327-x
Published Online: 2016-03-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jin, Zhen
Qing, Kai
Ouyang, Yuan
Liu, Zhao
Wang, Wenfang
Li, Xiaoyang
Xu, Zizhen
Li, Junmin
Funding for this research was provided by:
National Natural Sciences Foundation of China (81270621)
Natural Science Foundation of Shanghai (14ZR1425900)
